Insights

Fifteen+ years of
Healthcare thinking.

Several hundred perspectives on the questions facing payers, providers, biopharma, medtech, and digital health — plus our running read on the clinical literature. Start with our sharpest work, or filter to your world.

The New England Journal of Medicine

An opinionated take on NEJM highlights for the third quarter of 2024

  • NEJM
The new Humira? It’s not that often that you see industry-sponsored h…

Read more

The infectiologists have the floor: An opinionated take on NEJM highlights for March 2020

  • NEJM
A first Covid-19 interventional study – unfortunately negative The fir…

Read more